Evidence map›Paper›PMID 31534979›Full record

ArticleOrthopaedic journal of sports medicine2019

Chondrocytes From Device-Minced Articular Cartilage Show Potent Outgrowth Into Fibrin and Collagen Hydrogels.

Clara Levinson, Emma Cavalli, Dolman Mostafa Sindi, Benjamin Kessel, Marcy Zenobi-Wong, Stefan Preiss, Gian Salzmann, Philipp Neidenbach

Open access · goldAbstract read
In one paragraph

Article in Orthopaedic journal of sports medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Clara LevinsonTissue Engineering + Biofabrication Laboratory, ETH Zürich, Zürich, Switzerland.
Emma CavalliTissue Engineering + Biofabrication Laboratory, ETH Zürich, Zürich, Switzerland.
Dolman Mostafa SindiTissue Engineering + Biofabrication Laboratory, ETH Zürich, Zürich, Switzerland.
Benjamin KesselTissue Engineering + Biofabrication Laboratory, ETH Zürich, Zürich, Switzerland.
Marcy Zenobi-WongDepartment of Lower Extremity Orthopaedics, Musculoskeletal Centre, Schulthess Clinic, Zürich, Switzerland.
Stefan PreissDepartment of Lower Extremity Orthopaedics, Musculoskeletal Centre, Schulthess Clinic, Zürich, Switzerland.
Gian SalzmannDepartment of Lower Extremity Orthopaedics, Musculoskeletal Centre, Schulthess Clinic, Zürich, Switzerland.
Philipp NeidenbachDepartment of Lower Extremity Orthopaedics, Musculoskeletal Centre, Schulthess Clinic, Zürich, Switzerland.
ETH Zurich · CHSchulthess-Klinik · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransplantation of autologous minced cartilage is an established procedure to repair chondral lesions. It relies on the migration of chondrocytes out of cartilage particles into a biomaterial. So far, there is no efficient way to finely mince cartilage. No consensus exists on the nature of the biomaterial to be used to promote chondrocyte migration. PURPOSE/HYPOTHESIS: This study aimed to investigate the potential clinical use of a custom-made mincing device as well as a possible alternative biomaterial to fibrin glue. The device was tested for its effect on chondrocyte viability and on subsequent chondrocyte migration into either a fibrin or a collagen gel. We hypothesized that device mincing would allow finer cutting and consequently more cell migration and that the gelation mechanism of the collagen biomaterial, which uses the clotting of platelet-rich plasma, would enhance matrix production by outgrown chondrocytes. STUDY

designControlled laboratory study.

methodsCartilage from 12 patients undergoing knee arthroplasty was taken from the femoral condyles and subsequently either hand minced or device minced. The viability and the degree of outgrowth were quantified with live/dead assay on the generated cartilage particles and on the gels in which these particles were embedded, respectively. Matrix deposition in the biomaterials by the outgrown cells was investigated with histology.

resultsThe device allowed rapid mincing of the cartilage and produced significantly smaller pieces than hand mincing. The initial chondrocyte viability in cartilage particles dropped by 25% with device mincing as compared with no mincing. However, the viability in hand-minced, device-minced, and unminced samples was no longer different after 7 and 28 days in culture. Outgrowth scores were similar among the 3 groups. Fibrin and collagen biomaterials equally supported chondrocyte outgrowth and survival, but neither promoted matrix deposition after in vitro culture.

conclusionThe outgrowth potential, the viability after 28 days in culture, and the matrix deposition were not different between the mincing techniques and the tested biomaterials, yet device mincing is faster and results in significantly smaller cartilage particles. CLINICAL RELEVANCE: Device mincing could become the standard method to mince cartilage for second-generation cartilage repair techniques.

Indexed as

biomaterialscollagenfibrinknee articular cartilageoutgrowthparticulated cartilageplatelet-rich plasma

Identifiers

PMID31534979
PMCPMC6737879
OpenAlexW2973174476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.